October 12, 2022 02:46 PM EDTUpdated 04:54 PM
Pharma
Marketing

AMA, Ad Coun­cil and CDC re­boot flu shot cam­paign for fall

Beth Snyder Bulik

Senior Editor

With a wor­ri­some flu sea­son on the hori­zon, a trio of pub­lic health and ad­ver­tis­ing ex­perts is dust­ing off some in­fluen­za ads to pro­mote vac­ci­na­tions …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

No­vo Nordisk’s once-dai­ly he­mo­phil­ia drug Al­he­mo ap­proved in US

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

GSK's Ze­ju­la-Jem­per­li com­bo in ovar­i­an can­cer hits pri­ma­ry end­point, miss­es on over­all sur­vival

A service from the Financial Times